a public good project by the
Synthesis
Company
of California

© 2026

Kim Kramer | doi.page

0 works0 citations0 h-index

Kim Kramer

Royal Prince Alfred Hospital(AU)

Publications by Year

Research Areas

Neuroblastoma Research and Treatments, Glioma Diagnosis and Treatment, Cancer therapeutics and mechanisms, Lung Cancer Research Studies, Cancer, Hypoxia, and Metabolism

Most-Cited Works

→ Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers(2020)1,200 cited
→ Convection-enhanced delivery for diffuse intrinsic pontine glioma: a single-centre, dose-escalation, phase 1 trial(2018)265 cited
→ Murine Anti-GD2 Monoclonal Antibody 3F8 Combined With Granulocyte-Macrophage Colony-Stimulating Factor and 13-Cis-Retinoic Acid in High-Risk Patients With Stage 4 Neuroblastoma in First Remission(2012)254 cited
→ Compartmental intrathecal radioimmunotherapy: results for treatment for metastatic CNS neuroblastoma(2009)242 cited
→ Phase II Trial of the Anti-G_D2Monoclonal Antibody 3F8 and Granulocyte-Macrophage Colony-Stimulating Factor for Neuroblastoma(2001)205 cited
→ Anti-G(D2) antibody treatment of minimal residual stage 4 neuroblastoma diagnosed at more than 1 year of age.(1998)197 cited

→ Anaesthetic depth and complications after major surgery: an international, randomised controlled trial(2019)170 cited

→ Long‐term complications in survivors of advanced stage neuroblastoma(2005)169 cited

→ The impact of gross total resection on local control and survival in high-risk neuroblastoma(2004)167 cited

Monoclonal antibody 8H9 targets a novel cell surface antigen expressed by a wide spectrum of human solid tumors.(2001)